Table (1).
Baseline clinical participants' characteristics in both groups
| Mean ±SD | Significance | ||
| Intervention group (n:40) |
Control group (n:40) |
||
| Age (year) | 48.36 ± 5.12 | 47.17 ± 5.63 | P >0.05 |
| Gender (Male/Female) | 23/17 | 21/19 | P >0.05 |
| Weight (kg) | 88.92 ± 5.76 | 90.11± 6.24 | P >0.05 |
| Height (cm) | 169.17 ± 8.22 | 171.37 ± 7.81 | P >0.05 |
| Waist-hip ratio | 0.86 ± 0.05 | 0.88 ± 0.07 | P >0.05 |
| BMI (kg/m2) | 31.85 ± 3.46 | 32.24 ± 3.62 | P >0.05 |
| SBP (mm Hg) | 123.41 ± 7.23 | 125.16 ± 8.27 | P >0.05 |
| DBP (mm Hg) | 82.65 ± 6.81 | 84.12 ± 5.78 | P >0.05 |
| TC (mg/dl) | 193.14 ± 9.55 | 195.26 ±10.17 | P >0.05 |
| LDL-c (mg/dl) | 132.53 ± 7.11 | 135.16 ± 8.26 | P >0.05 |
| TG (mg/dl) | 154.05 ± 9.25 | 156.49 ±8.77 | P >0.05 |
| HDL-c (mg/dl) | 35.21 ± 2.15 | 33.85 ±2.36 | P >0.05 |
| HOMA-IR | 4.82 ± 1.67 | 4.96 ± 1.44 | P >0.05 |
| HbA1C (%) | 7.66±1.58 | 7.83±1.73 | P >0.05 |
| Diabetes duration (year) | 11.16 ± 2.11 | 12.24 ± 1.88 | P >0.05 |
BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; TC: Total cholesterol; LDL-c: Low-density lipoprotein cholesterol; TG: Triglyceride; HDL-c: High-density lipoprotein cholesterol; HOMA-IR: Homeostasis Model Assessment-Insulin Resistance Index; HbA1C: Glycosylated hemoglobin; * Significant level (p<0.05).